In vitro treatment of 3 T3-L1 adipocytes with recombinant Calcium/calmodulin-dependent Protein Kinase IV (CaMKIV) limits ER stress and improves insulin sensitivity through inhibition of autophagy via the mTOR/CREB signaling pathway

Peer Review reports

Original Submission
16 Dec 2019	Submitted	Original manuscript
13 Jan 2020	Author responded	Author comments - Jiali Liu
Resubmission - Version 2
13 Jan 2020	Submitted	Manuscript version 2
18 Jan 2020	Author responded	Author comments - Jiali Liu
Resubmission - Version 3
18 Jan 2020	Submitted	Manuscript version 3
21 Mar 2020	Reviewed	Reviewer Report
22 Mar 2020	Reviewed	Reviewer Report
24 Mar 2020	Reviewed	Reviewer Report - Abdelkarim Kamel
21 Apr 2020	Author responded	Author comments - Jiali Liu
Resubmission - Version 4
21 Apr 2020	Submitted	Manuscript version 4
25 Apr 2020	Reviewed	Reviewer Report
3 May 2020	Reviewed	Reviewer Report
14 May 2020	Reviewed	Reviewer Report - Abdelkarim Kamel
29 May 2020	Author responded	Author comments - Jiali Liu
Resubmission - Version 5
29 May 2020	Submitted	Manuscript version 5
4 Jun 2020	Reviewed	Reviewer Report
22 Jun 2020	Author responded	Author comments - Jiali Liu
Resubmission - Version 6
22 Jun 2020	Submitted	Manuscript version 6
Publishing
7 Jul 2020	Editorially accepted
13 Jul 2020	Article published	10.1186/s12902-020-00589-2

Back to article page